# 119-s-4885: Shandra Eisenga Human Cell and Tissue Product Safety Act

119-s-4885, Shandra Eisenga Human Cell and Tissue Product Safety Act, is a 119th Congress bill sponsored by Sen. Peters, Gary C. [D-MI] (D-MI); status introduced; PRIA reads it as touching household money (as of 2026-07-19).

- Canonical: https://policyrisk.com/legislation/119-s-4885
- As of: 2026-07-19
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-s-4885
- Congress: 119
- Title: Shandra Eisenga Human Cell and Tissue Product Safety Act
- Status: introduced
- Introduced: 2026-06-24
- Sponsor: Sen. Peters, Gary C. [D-MI] (D-MI)
- Cosponsors: 1
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-07-19

## Summary

**This bill would strengthen FDA oversight and public education for human cell and tissue products (HCTPs).** It aims to make guidance and data about HCTPs clearer so clinicians, patients, and industry can better understand donation, regulation, and safety. - Families and health care professionals: Would fund and distribute educational materials on organ, tissue, and eye donation, donor screening tests, and evidence-based ways to approach patients and families. - Tissue establishments and researchers: Would require the FDA to publish counts of registered HCT establishments and inspections from Jan 1, 2019 onward. It directs the agency to develop best practices, hold workshops, and help generate scientific data with reporting that starts within one year and continues for three years. - Enforcement and transparency: Would create civil penalties for violations of HCTP rules up to $20,000 per violation and $20,000 per day after written notice, plus the retail value of implicated products, capped at $10.0 million per proceeding. It would also open a public docket and require a report to Congress by Sept 30, 2026 with regulatory recommendations.

## Cosponsors (1)

- Sen. Marshall, Roger [R-KS] (R-KS), 2026-06-24T00:00:00.000Z

## Provisions PRIA read

- Public docket and regulatory workshops: benefit, medium. If enacted, the Secretary would open a public docket within 60 days to collect written comments on modernizing rules for human cell and tissue products. The FDA would run workshops and publish best practices to help developers get timely regulatory advice. The Secretary would summarize the workshop…
- Education on organ and tissue donation: benefit, low. If enacted, the Secretary would support creating and sharing educational materials for health care and other appropriate professionals about organ, tissue, and eye donation. Materials would include evidence-based ways to approach patients and families and information on any donor screening tests. T…
- New civil penalties for tissue sellers: cost, high. If enacted, this bill would let HHS fine people for certain human cell and tissue product rule violations. Penalties would be $20,000 for each violation. They would be $20,000 more for each day the violation continues after the Secretary gives written notice. The violator would also owe the retail…

## Related bills

- 119-s-5022: Cannabis Administration and Opportunity Act
- 119-s-2975: PIPELINE Safety Act of 2025
- 119-s-1748: Kids Online Safety Act
- 119-s-3265: Improve and Enhance the Work Opportunity Tax Credit Act
- 119-s-5283: Momnibus Act
- 119-s-2355: Patients Deserve Price Tags Act

## Sources
- [119-s-4885 on Congress.gov](https://www.congress.gov/bill/119th-congress/senate-bill/4885)

## Related
- [119-s-5022: Cannabis Administration and Opportunity Act](https://policyrisk.com/legislation/119-s-5022)
- [119-s-2975: PIPELINE Safety Act of 2025](https://policyrisk.com/legislation/119-s-2975)
- [119-s-1748: Kids Online Safety Act](https://policyrisk.com/legislation/119-s-1748)
- [119-s-3265: Improve and Enhance the Work Opportunity Tax Credit Act](https://policyrisk.com/legislation/119-s-3265)
- [119-s-5283: Momnibus Act](https://policyrisk.com/legislation/119-s-5283)
- [119-s-2355: Patients Deserve Price Tags Act](https://policyrisk.com/legislation/119-s-2355)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-s-4885 (as of 2026-07-19).